| Identification | Back Directory | [Name]
2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9,10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, (2Z)- | [CAS]
849693-09-0 | [Synonyms]
2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9,10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, (2Z)- | [Molecular Formula]
C20H28O6 | [MOL File]
849693-09-0.mol | [Molecular Weight]
364.43 |
| Hazard Information | Back Directory | [Uses]
Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL[1]. | [References]
[1] Qiong Gu, et al. Gilmane type sesquiterpene lactone compound and preparation method and application thereof. Patent CN112159378A. |
|
|